Martin Javier San, Chief Medical Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 19,500 shares at $69.39 ($1.4M) on 2020-11-19, disclosed to the SEC on 2020-11-20.
Open-market sale of $1.4M ARWR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATHA | SELL | 2025-07-02 | $3K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $6K | — | Filing → |
| ARWR | SELL | 2024-01-08 | $450K | — | Filing → |